O Wang1, Y Hu2, S Gong3, Q Xue4, Z Deng5, L Wang6, H Liu7, H Tang8, X Guo9, J Chen10, X Jia11, Y Xu12, L Lan13, C Lei14, H Dong15, G Yuan16, Q Fu17, Y Wei18, W Xia19, L Xu20. 1. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, China. 2. Banan People's Hospital of Chongqing, Chongqing, China. 3. Shenyang Orthopedics Hospital, Shenyang, Liaoning, China. 4. Beijing Hospital, Beijing, China. 5. The Second Hospital Affiliated to Chongqing Medical University, Chongqing, China. 6. The 309th Hospital of PLA, Beijing, China. 7. Beijing Jishuitan Hospital, Beijing, China. 8. Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, China. 9. Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. 10. People's Hospital of Zhejiang, Hangzhou, Zhejiang, China. 11. Wuyi First People's Hospital, Wuyi, Zhejiang, China. 12. The Second Hospital Affiliated to Suzhou University, Suzhou, Jiangsu, China. 13. Wuzhong People's Hospital of Suzhou, Wuzhong, Jiangsu, China. 14. General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China. 15. Shijingshan Teaching Hospital of Capital Medical University, Beijing Shijingshan Hospital, Beijing, China. 16. Xinzhou District People's Hospital of Wuhan, Wuhan, Hubei, China. 17. Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. 18. Yanchi Hospital, Yanchi, Ningxia, China. 19. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, China. xiaweibo@medmail.com.cn. 20. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 1 Shuai Fu Yuan, Beijing, 100730, China. xuling@pumch.cn.
Abstract
UNLABELLED: We found that the fragility hip and vertebral fractures caused excess mortality rates in this Chinese female population, which was unexpectedly lower than those in western countries and other Asian countries. This was the first nationwide survey relating to post-fracture outcomes conducted among Chinese population in Mainland China. INTRODUCTION: This study aimed to investigate the mortality, self-care ability, diagnosis, and medication treatment of osteoporosis following fragility hip and vertebral fractures through a nationwide survey among female patients aged over 50 in Mainland China. METHODS: This was a multicenter, retrospective cohort study based on medical chart review and patient questionnaire. Female patients aged 50 or older admitted for low-trauma hip or vertebral fractures and discharged from Jan 1, 2008 to Dec 31, 2012 were followed. RESULTS: Total of 1151 subjects of hip fracture and 842 subjects of vertebral fracture were included. The mean age was 73.4 ± 10.0, and the median of duration from index fracture to interview was 2.6 years. The overall 1-year, 2-year, 3-year, 4-year, and 5-year cumulative mortality rates were 3.5, 7.0, 11.2, 13.1, and 16.9 %, respectively. The first year mortality rates in hip (3.8 %, 95% CI 3.3-4.4 %) and vertebral fracture (3.1 %, 95% CI 2.5-3.7 %) were significantly higher than that in the general population (1.6 %). Impaired self-care ability was observed in 33.2, 40.6, and 23.8 % of overall, hip fracture, and vertebral fracture group, respectively. The overall diagnosis rate of osteoporosis was 56.8 %, and bone mineral density (BMD) measurement had never been conducted in 42.0 % among these women. After the index fracture, 69.6 % of them received supplements and/or anti-osteoporotic medications, among which 39.6 % only received calcium with/without vitamin D supplementation. CONCLUSIONS: The osteoporotic hip and vertebral fractures caused excess mortality rates in this population of Mainland China. The current diagnosis and medical treatment following the fragility fractures is still insufficient in Mainland China.
UNLABELLED: We found that the fragility hip and vertebral fractures caused excess mortality rates in this Chinese female population, which was unexpectedly lower than those in western countries and other Asian countries. This was the first nationwide survey relating to post-fracture outcomes conducted among Chinese population in Mainland China. INTRODUCTION: This study aimed to investigate the mortality, self-care ability, diagnosis, and medication treatment of osteoporosis following fragility hip and vertebral fractures through a nationwide survey among female patients aged over 50 in Mainland China. METHODS: This was a multicenter, retrospective cohort study based on medical chart review and patient questionnaire. Female patients aged 50 or older admitted for low-trauma hip or vertebral fractures and discharged from Jan 1, 2008 to Dec 31, 2012 were followed. RESULTS: Total of 1151 subjects of hip fracture and 842 subjects of vertebral fracture were included. The mean age was 73.4 ± 10.0, and the median of duration from index fracture to interview was 2.6 years. The overall 1-year, 2-year, 3-year, 4-year, and 5-year cumulative mortality rates were 3.5, 7.0, 11.2, 13.1, and 16.9 %, respectively. The first year mortality rates in hip (3.8 %, 95% CI 3.3-4.4 %) and vertebral fracture (3.1 %, 95% CI 2.5-3.7 %) were significantly higher than that in the general population (1.6 %). Impaired self-care ability was observed in 33.2, 40.6, and 23.8 % of overall, hip fracture, and vertebral fracture group, respectively. The overall diagnosis rate of osteoporosis was 56.8 %, and bone mineral density (BMD) measurement had never been conducted in 42.0 % among these women. After the index fracture, 69.6 % of them received supplements and/or anti-osteoporotic medications, among which 39.6 % only received calcium with/without vitamin D supplementation. CONCLUSIONS: The osteoporotic hip and vertebral fractures caused excess mortality rates in this population of Mainland China. The current diagnosis and medical treatment following the fragility fractures is still insufficient in Mainland China.
Authors: Wolfgang Brozek; Berthold Reichardt; Oliver Kimberger; Jochen Zwerina; Hans Peter Dimai; Daniela Kritsch; Klaus Klaushofer; Elisabeth Zwettler Journal: Calcif Tissue Int Date: 2014-07-03 Impact factor: 4.333
Authors: Patrick Haentjens; Jay Magaziner; Cathleen S Colón-Emeric; Dirk Vanderschueren; Koen Milisen; Brigitte Velkeniers; Steven Boonen Journal: Ann Intern Med Date: 2010-03-16 Impact factor: 25.391
Authors: O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson Journal: Osteoporos Int Date: 2003-10-30 Impact factor: 4.507
Authors: Sumit R Majumdar; Jeffrey A Johnson; Finlay A McAlister; Debbie Bellerose; Anthony S Russell; David A Hanley; Don W Morrish; Walter P Maksymowych; Brian H Rowe Journal: CMAJ Date: 2008-02-26 Impact factor: 8.262
Authors: Colleen J Metge; William D Leslie; Lori-Jean Manness; Marina Yogendran; C K Yuen; Brent Kvern Journal: Can Fam Physician Date: 2008-09 Impact factor: 3.275
Authors: P R Ebeling; D-C Chan; T C Lau; J K Lee; T Songpatanasilp; S H Wong; F L Hew; R Sethi; M Williams Journal: Osteoporos Int Date: 2019-12-01 Impact factor: 4.507
Authors: M Chandran; P J Mitchell; T Amphansap; S K Bhadada; M Chadha; D-C Chan; Y-S Chung; P Ebeling; N Gilchrist; A Habib Khan; P Halbout; F L Hew; H-P T Lan; T C Lau; J K Lee; S Lekamwasam; G Lyubomirsky; L B Mercado-Asis; A Mithal; T V Nguyen; D Pandey; I R Reid; A Suzuki; T T Chit; K L Tiu; T Valleenukul; C K Yung; Y L Zhao Journal: Osteoporos Int Date: 2021-01-27 Impact factor: 4.507
Authors: Suzanne M Dyer; Maria Crotty; Nicola Fairhall; Jay Magaziner; Lauren A Beaupre; Ian D Cameron; Catherine Sherrington Journal: BMC Geriatr Date: 2016-09-02 Impact factor: 3.921
Authors: Seth M Tarrrant; Amit Ajgaonkar; Sushrut Babhulkar; Zhiyong Cui; Ian A Harris; Sunil Kulkarni; Hiroaki Minehara; Takashi Miyamoto; Andrew Oppy; Kenji Shigemoto; Yun Tian; Zsolt J Balogh Journal: OTA Int Date: 2020-03-23